The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024.  Staff | Reuters Over the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a … Read more

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024.  Staff | Reuters Over the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a … Read more

Why we like health-care stocks in 2024 despite their spotty record in presidential election years

Why we like health-care stocks in 2024 despite their spotty record in presidential election years

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly , could defy historical … Read more

4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry

4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from the Covid straitjacket that so many of these companies got caught up in. The pandemic obscured … Read more

Walgreens and 3 other health-care stocks are going into our Bullpen watch list

Walgreens and 3 other health-care stocks are going into our Bullpen watch list

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim Cramer’s Charitable Trust. We’re highlighting the four most interesting investment opportunities we found out of the handful … Read more

Biden administration’s Medicare drug price negotiations will face major tests in 2024

Biden administration’s Medicare drug price negotiations will face major tests in 2024

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images U.S. patients and drugmakers will get a first glimpse of how much Medicare … Read more

Here are the big health sector themes to watch next year

Here are the big health sector themes to watch next year

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David W. Cerny | Reuters The health-care sector has wiped out much of its losses for the year during the December market rally. Beaten-down biotech and medical device … Read more

Novartis unit Sandoz set to start trading after completing spinoff

Novartis unit Sandoz set to start trading after completing spinoff

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its focus on its patented prescription medicines. Bloomberg | Bloomberg | Getty Images Novartis has completed the spinoff of its generics and biosimilars business Sandoz, which is set to debut … Read more

Drugmakers opt in to Medicare drug price negotiations – here’s what happens next

Drugmakers opt in to Medicare drug price negotiations – here’s what happens next

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters All drugmakers of the first 10 medicines selected for Medicare drug price negotiations have agreed to participate in the talks, … Read more

The ADHD drug market is already stretched thin. Now it’s facing a back-to-school supply strain

The ADHD drug market is already stretched thin. Now it’s facing a back-to-school supply strain

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Ten milligram tablets of the hyperactivity drug, Adderall, made by Shire Plc. Jb Reed | Bloomberg | Getty Images It’s been 10 months since the Food and Drug Administration first announced a nationwide shortage of Adderall — one of the most widely used medications for attention … Read more

CVS pushes into making cheaper versions of complex drugs with new discount Humira

CVS pushes into making cheaper versions of complex drugs with new discount Humira

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Rafael Henrique | Lightrocket | Getty Images CVS Health is partnering with drugmaker Sandoz to produce a near identical version of the blockbuster arthritis treatment Humira that will sell for 80% below the price of the brand-named drug. The move is part of the company’s new … Read more

Novartis shares jump after the drugmaker raised full-year guidance and launched a $15 billion buyback

Novartis shares jump after the drugmaker raised full-year guidance and launched a  billion buyback

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Novartis announced in August that it plans to spin off its Sandoz generics unit to focus more on its patented prescription drugs. Bloomberg | Bloomberg | Getty Images Novartis shares jumped on Tuesday after the Swiss drugmaker raised its full-year guidance to strong selling drugs and … Read more

Eli Lilly’s CEO says Medicare price negotiations could hurt drug development

Eli Lilly’s CEO says Medicare price negotiations could hurt drug development

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE David Ricks, CEO, Eli Lilly Scott Mlyn | CNBC Eli Lilly CEO David Ricks said Tuesday Medicare price negotiationswhose goal is reduce costs potentially harmful for older Americans drug development. “I’m really worried about the damage this will do to new drugs and opportunities in medicine,” … Read more

Radioligand therapy, a game-changer in cancer treatment, is forcing manufacturers to race against a ticking clock

Radioligand therapy, a game-changer in cancer treatment, is forcing manufacturers to race against a ticking clock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A Novartis production associate checks punches on a press machine. Source: Novartis In 2010, a volcano erupted in Iceland. For dr. That was the problem for Oliver Sartor, a professor of cancer research at Tulane University School of Medicine. Ash from the eruption disrupted flights across … Read more

Elizabeth Holmes ’case is coming to an end as the government says it will be dormant next week

Elizabeth Holmes ’case is coming to an end as the government says it will be dormant next week

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Elizabeth Holmes, founder and CEO of Theranos Mike Blake Reuters SAN JOSE, Calif. – In a surprising announcement Wednesday, the government announced it would likely close a lawsuit against former Theranos CEO Elizabeth Holmes at her trial for fraud next week. “The government is likely to … Read more

;
error: Content is protected !!